Autoimmune Diseases Affecting Hemostasis: A Narrative Review

Emmanuel J Favaloro, Leonardo Pasalic, Giuseppe Lippi

Research output: Contribution to journalReview articlepeer-review


Hemostasis reflects a homeostatic mechanism that aims to balance out pro-coagulant and anti-coagulant forces to maintain blood flow within the circulation. Simplistically, a relative excess of procoagulant forces can lead to thrombosis, and a relative excess of anticoagulant forces can lead to bleeding. There are a wide variety of congenital disorders associated with bleeding or thrombosis. In addition, there exist a vast array of autoimmune diseases that can also lead to either bleeding or thrombosis. For example, autoantibodies generated against clotting factors can lead to bleeding, of which acquired hemophilia A is the most common. As another example, autoimmune-mediated antibodies against phospholipids can generate a prothrombotic milieu in a condition known as antiphospholipid (antibody) syndrome (APS). Moreover, there exist various autoimmunity promoting environments that can lead to a variety of antibodies that affect hemostasis. Coronavirus disease 2019 (COVID-19) represents perhaps the contemporary example of such a state, with potential development of a kaleidoscope of such antibodies that primarily drive thrombosis, but may also lead to bleeding on rarer occasions. We provide here a narrative review to discuss the interaction between various autoimmune diseases and hemostasis.

Original languageEnglish
Article number14715
JournalInternational Journal of Molecular Sciences
Issue number23
Publication statusPublished - Dec 2022


Dive into the research topics of 'Autoimmune Diseases Affecting Hemostasis: A Narrative Review'. Together they form a unique fingerprint.

Cite this